Stay updated on BCD-021 vs Avastin in NSCLC Clinical Trial
Sign up to get notified when there's something new on the BCD-021 vs Avastin in NSCLC Clinical Trial page.

Latest updates to the BCD-021 vs Avastin in NSCLC Clinical Trial page
- CheckyesterdayChange DetectedThe web page has undergone significant updates, including the addition of various facility names and locations in Russia and Belarus, while removing previous references to the Russian Federation and certain medical topics. The revision number has also been updated from v2.16.12 to v3.0.0.SummaryDifference14%
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check22 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check30 days agoChange DetectedThe page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference0.9%
- Check37 days agoChange DetectedThe page has been updated to reflect a new version, changing from Revision v2.16.6 to v2.16.8, and includes a new section on HHS Vulnerability Disclosure.SummaryDifference0.2%
- Check44 days agoChange DetectedThe web page has been updated from version 2.16.5 to version 2.16.6.SummaryDifference0.1%
Stay in the know with updates to BCD-021 vs Avastin in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BCD-021 vs Avastin in NSCLC Clinical Trial page.